SCHEMBL4351663

SCHEMBL4351663

Cc1ccccc1[S+](c1ccccc1)c1ccccc1.O=C(OCC(F)(F)S(=O)(=O)O)C1CCCCC1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
ALDH1A1 P00352 8/20 0.38
CYP2C19 P33261 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
NPSR1 Q6W5P4 2/20 0.37
PKM P14618 1/20 0.37
HSD17B10 Q99714 2/20 0.37
HTR7 P34969 2/20 0.36
HTR1A P08908 1/20 0.36
DRD2 P14416 1/20 0.36
HTR2A P28223 1/20 0.36
TP53 P04637 1/20 0.36
MAPT P10636 1/20 0.36
TSHR P16473 1/20 0.36
TDP1 Q9NUW8 1/20 0.35
HTT P42858 1/20 0.35
KDM4E B2RXH2 1/20 0.35
ATM Q13315 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4353897 0.86 TDP1 (0.37) MEN1KMT2AALDH1A1SMN1; SMN2MAPT
SCHEMBL3454523 0.85 MIF (0.36) MEN1KMT2AALDH1A1CYP2C19NPSR1
SCHEMBL4352148 0.82 HPGD (0.35) MEN1KMT2AALDH1A1NPSR1PKM
SCHEMBL3454245 0.80 ELANE (0.38) MEN1KMT2AALDH1A1CYP2C19SMN1; SMN2
SCHEMBL3756010 0.80 ALDH1A1 (0.38) MEN1KMT2AALDH1A1CYP2C19NPSR1
SCHEMBL4351667 0.80 MEN1 (0.46) MEN1KMT2AALDH1A1CYP2C19NPSR1
SCHEMBL2428262 0.79 SMN1; SMN2 (0.40) KMT2AALDH1A1SMN1; SMN2TSHRHTT
SCHEMBL2422774 0.78 ALDH1A1 (0.39) KMT2AALDH1A1CYP2C19SMN1; SMN2NPSR1
SCHEMBL2425912 0.78 KDM4E (0.39) MEN1KMT2AALDH1A1CYP2C19SMN1; SMN2
SCHEMBL597324 0.78 TAAR1 (0.36) MEN1KMT2AALDH1A1CYP2C19HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8779183-B2 Acid generating agent for chemically amplified resist compositions KOREA KUMHO PETROCHEMICAL CO., LTD. (KR) 2014-07-15 US disclosed
US-20090234155-A1 Acid generating agent for chemically amplified resist compositions KOREA KUMHO PETROCHEMICAL CO., LTD. (KR) 2009-09-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090234155-A1 Acid generating agent for chemically amplified resist compositions POLM, CBR1, PFAS MEN1 3542/4885KMT2A 1547/4885ALDH1A1 346/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.